Mutant p53 Gain-of-Function in Cancer

被引:594
作者
Oren, Moshe [1 ]
Rotter, Varda [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
关键词
LI-FRAUMENI-SYNDROME; P53-INDEPENDENT APOPTOTIC PATHWAYS; LUNG-SPECIFIC EXPRESSION; TUMOR-SUPPRESSOR P53; GENE-EXPRESSION; TGF-BETA; FUNCTION PHENOTYPE; WILD-TYPE; FUNCTION MUTATIONS; TRANSGENIC MICE;
D O I
10.1101/cshperspect.a001107
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In its wild-type form, p53 is a major tumor suppressor whose function is critical for protection against cancer. Many human tumors carry missense mutations in the TP53 gene, encoding p53. Typically, the affected tumor cells accumulate excessive amounts of the mutant p53 protein. Various lines of evidence indicate that, in addition to abrogating the tumor suppressor functions of wild-type p53, the common types of cancer-associated p53 mutations also endow the mutant protein with new activities that can contribute actively to various stages of tumor progression and to increased resistance to anticancer treatments. Collectively, these activities are referred to as mutant p53 gain-of-function. This article addresses the biological manifestations of mutant p53 gain-of-function, the underlying molecular mechanisms, and their possible clinical implications.
引用
收藏
页数:15
相关论文
共 105 条
[1]   A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis [J].
Adorno, Maddalena ;
Cordenonsi, Michelangelo ;
Montagner, Marco ;
Dupont, Sirio ;
Wong, Christine ;
Hann, Byron ;
Solari, Aldo ;
Bobisse, Sara ;
Rondina, Maria Beatrice ;
Guzzardo, Vincenza ;
Parenti, Anna R. ;
Rosato, Antonio ;
Bicciato, Silvio ;
Balmain, Allan ;
Piccolo, Stefano .
CELL, 2009, 137 (01) :87-98
[2]  
Albor A, 1998, CANCER RES, V58, P2091
[3]   Transcriptional Regulation by p53 [J].
Beckerman, Rachel ;
Prives, Carol .
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (08) :a000935
[4]   Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy [J].
Blandino, G ;
Levine, AJ ;
Oren, M .
ONCOGENE, 1999, 18 (02) :477-485
[5]   Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression [J].
Bossi, G ;
Lapi, E ;
Strano, S ;
Rinaldo, C ;
Blandino, G ;
Sacchi, A .
ONCOGENE, 2006, 25 (02) :304-309
[6]   Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy [J].
Bossi, Gianluca ;
Marampon, Francesco ;
Maor-Aloni, Revital ;
Zani, Bianca ;
Rotter, Varda ;
Oren, Moshe ;
Strano, Sabrina ;
Blandino, Giovanni ;
Sacchi, Ada .
CELL CYCLE, 2008, 7 (12) :1870-1879
[7]  
BROSH R, 2009, NATURE REV IN PRESS
[8]   Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction [J].
Buganim, Yosef ;
Kalo, Eyal ;
Brosh, Ran ;
Besserglick, Hila ;
Nachmany, Ido ;
Rais, Yoach ;
Stambolsky, Perry ;
Tang, Xiaohu ;
Milyavsky, Michael ;
Shats, Igor ;
Kalis, Marina ;
Goldfinger, Naomi ;
Rotter, Varda .
CANCER RESEARCH, 2006, 66 (22) :10750-10759
[9]   Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs [J].
Bykov, VJN ;
Issaeva, N ;
Zache, N ;
Shilov, A ;
Hultcrantz, M ;
Bergman, J ;
Selivanova, G ;
Wiman, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (34) :30384-30391
[10]   Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound [J].
Bykov, VJN ;
Issaeva, N ;
Shilov, A ;
Hultcrantz, M ;
Pugacheva, E ;
Chumakov, P ;
Bergman, J ;
Wiman, KG ;
Selivanova, G .
NATURE MEDICINE, 2002, 8 (03) :282-288